 |
News archive
Past news articles from The Rarer Cancers Forum
|
| Latest News |
Some good news from NICE!
Wed, 25 Jun 2008
NICE has announced that BaracludeŽ (entecavir) is recommended as an option for treatment of eligible patients with chronic hepatitis B.
|
|
|
|
 |